Selected research
Market Structure
Global Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Painkillers market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Painkillers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Painkillers include Sanofi, Johnson & Johnson, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Purdue Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Painkillers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Painkillers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Painkillers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Painkillers market size, projected growth trends, production technologies, key applications, and end-use industries.
Painkillers Segment by Company
Sanofi
Johnson & Johnson
Johnson & Johnson
Novartis
Merck
Roche
Eli Lilly
Pfizer
Purdue Pharma
Novavax
GlaxoSmithKline
Celgene
Astrazeneca
Painkillers Segment by Type
Opioids
Aspirin and NSAIDs
Paracetamol
Painkillers Segment by Application
Dental Pain
Trauma
Headache
Dysmenorrhoea (Painful Menstruation)
Bone Pain
Arthritis
Painkillers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Painkillers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Painkillers market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Painkillers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Painkillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Painkillers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Opioids
- Aspirin and NSAIDs
- Paracetamol
Applications
- Dental Pain
- Trauma
- Headache
- Dysmenorrhoea (Painful Menstruation)
- Bone Pain
- Arthritis
Companies covered
- Sanofi
- Johnson & Johnson
- Johnson & Johnson
- Novartis
- Merck
- Roche
- Eli Lilly
- Pfizer
- Purdue Pharma
- Novavax
- GlaxoSmithKline
- Celgene
- Astrazeneca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Painkillers Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Painkillers Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Painkillers Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Painkillers Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Painkillers Market Dynamics
- 2.1 Painkillers Industry Trends
- 2.2 Painkillers Industry Drivers
- 2.3 Painkillers Industry Opportunities and Challenges
- 2.4 Painkillers Industry Restraints
3 Painkillers Market by Manufacturers
- 3.1 Global Painkillers Revenue by Manufacturers (2021-2026)
- 3.2 Global Painkillers Sales by Manufacturers (2021-2026)
- 3.3 Global Painkillers Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Painkillers Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Painkillers Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Painkillers Manufacturers, Product Type & Application
- 3.7 Global Painkillers Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Painkillers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Painkillers Players Market Share by Revenue in 2025
- 3.8.3 2025 Painkillers Tier 1, Tier 2, and Tier 3
4 Painkillers Market by Type
- 4.1 Painkillers Type Introduction
- 4.1.1 Opioids
- 4.1.2 Aspirin and NSAIDs
- 4.1.3 Paracetamol
- 4.2 Global Painkillers Sales by Type
- 4.2.1 Global Painkillers Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Painkillers Sales by Type (2021-2032)
- 4.2.3 Global Painkillers Sales Market Share by Type (2021-2032)
- 4.3 Global Painkillers Revenue by Type
- 4.3.1 Global Painkillers Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Painkillers Revenue by Type (2021-2032)
- 4.3.3 Global Painkillers Revenue Market Share by Type (2021-2032)
5 Painkillers Market by Application
- 5.1 Painkillers Application Introduction
- 5.1.1 Dental Pain
- 5.1.2 Trauma
- 5.1.3 Headache
- 5.1.4 Dysmenorrhoea (Painful Menstruation)
- 5.1.5 Bone Pain
- 5.1.6 Arthritis
- 5.2 Global Painkillers Sales by Application
- 5.2.1 Global Painkillers Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Painkillers Sales by Application (2021-2032)
- 5.2.3 Global Painkillers Sales Market Share by Application (2021-2032)
- 5.3 Global Painkillers Revenue by Application
- 5.3.1 Global Painkillers Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Painkillers Revenue by Application (2021-2032)
- 5.3.3 Global Painkillers Revenue Market Share by Application (2021-2032)
6 Global Painkillers Sales by Region
- 6.1 Global Painkillers Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Painkillers Sales by Region (2021-2032)
- 6.2.1 Global Painkillers Sales by Region (2021-2026)
- 6.2.2 Global Painkillers Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Painkillers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Painkillers Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Painkillers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Painkillers Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Painkillers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Painkillers Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Painkillers Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Painkillers Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Painkillers Revenue by Region
- 7.1 Global Painkillers Revenue by Region
- 7.1.1 Global Painkillers Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Painkillers Revenue by Region (2021-2026)
- 7.1.3 Global Painkillers Revenue by Region (2027-2032)
- 7.1.4 Global Painkillers Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Painkillers Revenue (2021-2032)
- 7.2.2 North America Painkillers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Painkillers Revenue (2021-2032)
- 7.3.2 Europe Painkillers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Painkillers Revenue (2021-2032)
- 7.4.2 Asia-Pacific Painkillers Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Painkillers Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Painkillers Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Painkillers Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Painkillers Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Company Information
- 8.3.2 Johnson & Johnson Business Overview
- 8.3.3 Johnson & Johnson Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Johnson & Johnson Painkillers Product Portfolio
- 8.3.5 Johnson & Johnson Recent Developments
- 8.4 Novartis
- 8.4.1 Novartis Company Information
- 8.4.2 Novartis Business Overview
- 8.4.3 Novartis Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Novartis Painkillers Product Portfolio
- 8.4.5 Novartis Recent Developments
- 8.5 Merck
- 8.5.1 Merck Company Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Merck Painkillers Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 Roche
- 8.6.1 Roche Company Information
- 8.6.2 Roche Business Overview
- 8.6.3 Roche Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Roche Painkillers Product Portfolio
- 8.6.5 Roche Recent Developments
- 8.7 Eli Lilly
- 8.7.1 Eli Lilly Company Information
- 8.7.2 Eli Lilly Business Overview
- 8.7.3 Eli Lilly Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Eli Lilly Painkillers Product Portfolio
- 8.7.5 Eli Lilly Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Painkillers Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 Purdue Pharma
- 8.9.1 Purdue Pharma Company Information
- 8.9.2 Purdue Pharma Business Overview
- 8.9.3 Purdue Pharma Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Purdue Pharma Painkillers Product Portfolio
- 8.9.5 Purdue Pharma Recent Developments
- 8.10 Novavax
- 8.10.1 Novavax Company Information
- 8.10.2 Novavax Business Overview
- 8.10.3 Novavax Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Novavax Painkillers Product Portfolio
- 8.10.5 Novavax Recent Developments
- 8.11 GlaxoSmithKline
- 8.11.1 GlaxoSmithKline Company Information
- 8.11.2 GlaxoSmithKline Business Overview
- 8.11.3 GlaxoSmithKline Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 GlaxoSmithKline Painkillers Product Portfolio
- 8.11.5 GlaxoSmithKline Recent Developments
- 8.12 Celgene
- 8.12.1 Celgene Company Information
- 8.12.2 Celgene Business Overview
- 8.12.3 Celgene Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Celgene Painkillers Product Portfolio
- 8.12.5 Celgene Recent Developments
- 8.13 Astrazeneca
- 8.13.1 Astrazeneca Company Information
- 8.13.2 Astrazeneca Business Overview
- 8.13.3 Astrazeneca Painkillers Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Astrazeneca Painkillers Product Portfolio
- 8.13.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Painkillers Value Chain Analysis
- 9.1.1 Painkillers Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Painkillers Production Mode & Process
- 9.2 Painkillers Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Painkillers Distributors
- 9.2.3 Painkillers Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst